Probiotics are live microorganisms that, when consumed in adequate amounts, produce measurable effects throughout your body. They work primarily in the gut, where they compete with harmful bacteria for space and resources, strengthen the intestinal lining, produce vitamins and fatty acids your body needs, and send chemical signals that influence your immune system and even your brain. Most probiotic supplements contain between 1 and 10 billion colony-forming units (CFU) per dose, though the number on the label matters less than the specific strain inside.
How Probiotics Work in Your Gut
Probiotics don’t just passively sit in your intestines. They actively reshape the environment in several ways. First, they compete directly with harmful microorganisms for nutrients and binding sites along the intestinal wall. By physically occupying space on the gut lining, they crowd out bacteria that could otherwise cause infection or inflammation. Some strains go further, producing antimicrobial compounds that actively suppress the growth of harmful microbes.
Second, probiotics ferment fiber and other nondigestible carbohydrates in your gut, converting them into short-chain fatty acids like butyrate, propionate, and acetate. These fatty acids serve as fuel for the cells lining your colon and help regulate inflammation throughout the body. They also produce vitamins as a byproduct of their metabolism.
Third, probiotics strengthen the physical barrier of your intestinal wall. They help maintain the tight junctions between cells and stimulate mucus production, both of which prevent bacteria and toxins from leaking through the gut lining into your bloodstream. This barrier function is one reason probiotics show benefits for conditions involving intestinal inflammation, like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
Digestive Benefits
The strongest evidence for probiotics is in digestive health. In IBS, a systematic review comparing dozens of strains found that several significantly reduced overall symptom severity, abdominal pain, and bloating compared to placebo. The benefits weren’t limited to one type of symptom. Specific strains reduced how often people with diarrhea-predominant IBS had bowel movements, improved stool consistency, and eased bloating. Pain scores dropped meaningfully across multiple strains, though the degree of improvement varied.
Beyond IBS, certain strains have been tested specifically for preventing antibiotic-associated diarrhea, a common side effect when antibiotics wipe out beneficial gut bacteria along with the targeted infection. Lactobacillus rhamnosus GG (often sold as Culturelle) is one of the most widely studied strains for this purpose and has also shown benefit in shortening the duration of infectious diarrhea by roughly one day. Saccharomyces boulardii (sold as Florastor), a beneficial yeast rather than a bacterium, has been tested for preventing both antibiotic-associated diarrhea and recurrence of C. difficile infection.
Immune System Effects
About 70% of your immune system resides in and around your gut, which makes probiotics well positioned to influence immune function. They affect both your innate immune response (the first line of defense) and your adaptive immune response (the targeted, longer-term defense). Probiotics produce lactic acid, bacteriocins, and other substances that directly inhibit pathogens, while also changing intestinal pH to create an environment hostile to harmful bacteria.
On a deeper level, probiotics modulate the behavior of T cells, a critical component of adaptive immunity. They influence how helper T cells differentiate, which determines whether your immune system ramps up inflammation or dials it back. Certain strains stimulate the production of regulatory T cells that keep inflammatory responses in check. In animal and early human studies, Bifidobacterium adolescentis reduced inflammatory signaling molecules while boosting anti-inflammatory ones, helping to rebalance the immune response in chronic colitis. Maternal supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis has been shown to strengthen immune protection in newborns against viral infections by enhancing the activity of killer T cells.
The Gut-Brain Connection
Your gut and brain communicate through a network of nerves, hormones, and chemical messengers collectively known as the gut-brain axis. Gut bacteria, including probiotics, directly produce neurotransmitters: serotonin, dopamine, GABA, acetylcholine, norepinephrine, and histamine are all manufactured by microbes in the intestine. Probiotics can alter the levels of these chemicals, which in turn affect mood, stress responses, and cognitive function.
Clinical data backs this up. In the IBS network meta-analysis, one Bifidobacterium longum strain significantly reduced scores on a standardized anxiety and depression scale, while another strain of the same species specifically lowered depression scores. These weren’t dramatic transformations, but they were statistically meaningful and consistent with the idea that shifting gut microbiology can influence mental health.
Not All Strains Do the Same Thing
One of the most important things to understand about probiotics is that benefits are strain-specific. A Lactobacillus rhamnosus product and a Bifidobacterium infantis product are not interchangeable, even though both are “probiotics.” Choosing based on the condition you want to address matters more than choosing based on total CFU count. Products with higher CFU numbers are not necessarily more effective than those with lower counts.
Here’s a simplified guide based on clinical testing:
- IBS symptoms: Bifidobacterium infantis 35624, Lactobacillus plantarum 299v, and multi-strain combinations like VSL#3 have all shown benefit for pain, bloating, or overall symptom scores.
- Antibiotic-associated diarrhea prevention: Lactobacillus rhamnosus GG, Lactobacillus acidophilus CL1285 combined with Lactobacillus casei, and Saccharomyces boulardii.
- Infectious diarrhea (treatment and prevention): Lactobacillus rhamnosus GG and Lactobacillus reuteri. In children, LGG reduced both severity and duration of diarrhea, with roughly 1 in 7 children treated avoiding a case of rotavirus in a childcare setting.
- Ulcerative colitis maintenance: E. coli Nissle 1917 and VSL#3 have been tested for inducing and maintaining remission.
- C. difficile recurrence prevention: Saccharomyces boulardii and Lactobacillus rhamnosus GG.
Food Sources of Probiotics
You don’t need a supplement to get probiotics. Fermented foods naturally contain live bacteria, though the specific strains and concentrations vary. Kefir is one of the most microbiologically diverse options, containing dozens of bacterial and yeast species including multiple Lactobacillus strains, Streptococcus thermophilus, and beneficial yeasts. Kimchi contains Lactobacillus, Leuconostoc, and Weissella bacteria. Yogurt with live active cultures typically includes Lactobacillus bulgaricus and Streptococcus thermophilus, and some brands add additional strains.
Fermented dairy products can reach concentrations of up to 1 billion CFU per milliliter, putting them in the same range as many supplement capsules. The trade-off is that you have less control over exactly which strains you’re consuming, and concentrations can vary between batches. If you’re targeting a specific condition, a supplement with a clinically tested strain gives you more precision. For general gut health, regularly eating a variety of fermented foods is a reasonable approach.
Most Probiotics Don’t Survive Your Stomach
A major challenge with probiotics is getting live organisms past your stomach acid. In laboratory simulations of the digestive tract, only about 5% of bifidobacteria and 1% of Lactobacillus gasseri survived the stomach when delivered as unprotected powder. By the time they passed through the full gastrointestinal tract, survival dropped to 2% and 0.1%, respectively.
Enteric-coated tablets, designed to resist stomach acid and dissolve in the small intestine, dramatically improve these numbers. The same study found that enteric coating increased survival through the stomach to 72% for bifidobacteria and 53% for Lactobacillus gasseri, a 20- to 40-fold improvement. This is worth considering when choosing a product format: capsules with delayed-release or enteric coatings deliver significantly more viable bacteria to the part of your gut where they actually work.
How Long Before You Notice Effects
Probiotic bacteria show up in stool samples within one to two days of starting supplementation, confirming they’re making it through the digestive tract alive. But reaching your gut and producing noticeable changes are different things. Most clinical trials showing digestive benefits run for four to eight weeks, which is a reasonable timeline to expect before evaluating whether a particular strain is helping you.
Once you stop taking probiotics, the supplemented strains typically wash out of your system within three to six days, though this varies by strain and by individual. One strain of Bifidobacterium longum persisted for 8.5 days on average in people with intermediate gut transit times, and nearly half of that group retained the strain for 15 days or longer. Probiotics generally don’t permanently colonize your gut. They work while you keep taking them.
Side Effects and Safety Risks
For most people, probiotics cause nothing worse than temporary gas, bloating, or mild abdominal cramping as the gut adjusts. These minor symptoms typically resolve within the first few days to a week.
The serious risks are rare but real, and they almost exclusively affect people with compromised immune systems or specific medical vulnerabilities. Case reports have documented bloodstream infections from probiotic organisms, including at least 33 cases of fungal infection from Saccharomyces boulardii and at least eight cases of bacterial infection from various Lactobacillus strains. Cases of sepsis and heart valve infections have also been reported, though again in very small numbers relative to how widely probiotics are used.
The populations at highest risk include people on immunosuppressive drugs (after organ transplants, during chemotherapy, or on high-dose corticosteroids), people with structural heart disease or replacement valves, hospitalized patients with central venous catheters, and anyone with active intestinal disease that could allow bacteria to cross the gut wall into the bloodstream. Premature infants and people with short bowel syndrome also face elevated risk.

